Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

FORLANO, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.093
NA - Nord America 899
SA - Sud America 725
EU - Europa 214
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 65
Totale 3.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 836
BR - Brasile 561
SG - Singapore 330
VN - Vietnam 325
CN - Cina 274
DE - Germania 116
AR - Argentina 74
MA - Marocco 69
HK - Hong Kong 47
EC - Ecuador 38
ID - Indonesia 36
MX - Messico 31
FR - Francia 26
IT - Italia 20
PK - Pakistan 19
BD - Bangladesh 18
ZA - Sudafrica 17
CO - Colombia 15
IN - India 15
PY - Paraguay 14
RU - Federazione Russa 14
CA - Canada 13
GB - Regno Unito 11
CL - Cile 7
EG - Egitto 6
VE - Venezuela 6
AT - Austria 5
DO - Repubblica Dominicana 5
HN - Honduras 5
IQ - Iraq 5
UY - Uruguay 5
DZ - Algeria 4
FI - Finlandia 4
NL - Olanda 4
PE - Perù 4
CR - Costa Rica 3
NP - Nepal 3
SE - Svezia 3
AL - Albania 2
AZ - Azerbaigian 2
ES - Italia 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
PL - Polonia 2
RS - Serbia 2
SN - Senegal 2
TR - Turchia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
Totale 3.034
Salva come PNG Salva come JPEG
Città #
Dallas 506
Singapore 156
Ho Chi Minh City 128
Frankfurt am Main 96
Ashburn 73
Hefei 65
Casablanca 63
The Dalles 58
Hanoi 53
Beijing 49
Hong Kong 43
San Jose 40
São Paulo 36
Los Angeles 29
Mexico City 18
Guayaquil 16
Rio de Janeiro 16
Curitiba 15
Haiphong 15
Islamabad 15
New York 14
Da Nang 12
Thái Bình 11
Brasília 10
Quito 10
Bắc Giang 9
Johannesburg 9
Munich 9
Porto Alegre 9
Asunción 8
Biên Hòa 8
Düsseldorf 8
Jakarta 8
Buenos Aires 7
Belo Horizonte 6
Campinas 6
Chicago 6
Guarulhos 6
Hillsboro 6
Hải Dương 6
Ribeirão Preto 6
Santa Clara 6
Cao Lanh 5
Fortaleza 5
Lauterbourg 5
Montreal 5
Ninh Bình 5
Sorocaba 5
Sumaré 5
São José dos Campos 5
Thái Nguyên 5
Belford Roxo 4
Canoas 4
Caxias do Sul 4
Chennai 4
Columbus 4
Corrientes 4
Cotia 4
Formosa 4
Huế 4
Maceió 4
Milan 4
Monterrey 4
Montes Claros 4
New Delhi 4
Orem 4
Ourinhos 4
Paulista 4
Recife 4
Santo André 4
St Petersburg 4
São Gonçalo 4
Taboão da Serra 4
Turku 4
Algiers 3
Atlanta 3
Bogotá 3
Brooklyn 3
Bắc Ninh 3
Can Tho 3
Cape Town 3
Contagem 3
Curvelo 3
Goiânia 3
Hortolândia 3
Juiz de Fora 3
Lima 3
Lomas de Zamora 3
London 3
Lấp Vò 3
Mauá 3
Medellín 3
Mogi das Cruzes 3
Montevideo 3
Newark 3
Novo Hamburgo 3
Phoenix 3
Phủ Lý 3
Quận Một 3
San José 3
Totale 1.885
Salva come PNG Salva come JPEG
Nome #
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver 211
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII 163
Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus 72
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 66
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective 62
A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies 59
Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study 59
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 59
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease 56
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease 56
Current and future pharmacological therapies for managing cirrhosis and its complications 56
Automated quantitation of histological features could predict mortality in patients with severe alcoholic hepatitis 56
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 55
Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease 55
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 53
Binge Eating Disorder is associated with an unfavourable body mass composition in patients with Non-Alcoholic fatty liver disease 53
Automated quantitation of steatosis, inflammation, ballooning and fibrosis using machine learning in routine histological images of liver biopsies of patients with NAFLD 52
Current and future pharmacological therapies for managing cirrhosis and its complications 52
Deep Learning in Liver Biopsies using Convolutional Neural Networks 52
A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients 50
Another arrow in the NASH quiver? 48
NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials 48
Quantification of Liver Fibrosis-A Comparative Study 47
Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts 47
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 45
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learning 43
A prospective cohort study for the prevalence and screening policy of NAFLD in patients with T2DM in primary care 43
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 43
Liver function tests in NAFLD: Changes in upper normal limits, does it really matter? 43
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 43
Detection of senescence using machine learning algorithms based on nuclear features 43
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply 42
IN-HOSPITAL MORTALITY IS ASSOCIATED WITH INFLAMMATORY RESPONSE IN NAFLD PATIENTS ADMITTED FOR COVID-19 41
Non-alcoholic fatty liver disease and cardiovascular risk: an update 41
Training of Deep Convolutional Neural Networks to Identify Critical Liver Alterations in Histopathology Image Samples 41
Fat Droplets Identification in Liver Biopsies using Supervised Learning Techniques 41
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 41
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply 40
Liver function tests in NAFLD: Changes in upper normal limits, does it really matter? 40
Evaluating the impact of non-selective beta-blocker use in decompensated cirrhosis based on setting of patient care 38
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 38
IMPACT OF BMI AND ETHNICITY ON HISTOLOGY AS ASSESSED BY AUTOMATED QUANTITATION IN LIVER BIOPSIES OF PATIENTS WITH NAFLD 38
THE ROLE OF SUB-MUCOSAL COLLAGEN DEPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 37
Automated Quantitation of Steatosis, Fibrosis and Ballooning Using Machine Learning in Routine Histological Images of Liver Biopsies of Patients with NAFLD 37
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 36
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease: The importance of an elevated mean platelet volume 36
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19 35
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease 35
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie SocietA Italiana di Medicina Interna) Study 35
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply 34
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply 34
SUB-MUCOSAL COLLAGEN DEPOSITION IS ASSOCIATED WITH INFLAMMATION MARKERS AND DISEASE ACTIVITY INDICES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: AN ONGOING STUDY 34
Screening for NAFLD-Current Knowledge and Challenges 34
Letter: liver disease and COVID-19-not the perfect storm 34
Ensemble Convolutional Neural Network Classification for Pancreatic Steatosis Assessment in Biopsy Images 34
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume 33
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 33
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 33
Non-alcoholic fatty liver disease and cardiovascular risk: an update 32
Non-Alcoholic Fatty Liver Disease and Vascular Disease 32
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review 32
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease 31
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 30
Multi-tissue pro fi ling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue in fl ammation and liver steatosis in obesity 30
Transfer Learning versus Custom CNN Architectures in NAFLD Biopsy Images 27
Totale 3.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025282 0 0 0 0 0 0 0 0 160 34 76 12
2025/20262.775 73 345 682 900 155 42 125 113 77 195 51 17
2026/202742 12 30 0 0 0 0 0 0 0 0 0 0
Totale 3.099